Leadership Overview
Bio-Techne has 8 executives leading key functions including technology, finance, human resources, information technology, financial operations, protein sciences, and diagnostics.
Driven by scientific advancement, Bio-Techne provides innovative tools and bioactive reagents for research and clinical diagnostics, accelerating discoveries in biological processes and disease progression while enabling accurate clinical tests.
Driven by scientific advancement, Bio-Techne provides innovative tools and bioactive reagents for research and clinical diagnostics, accelerating discoveries in biological processes and disease progression while enabling accurate clinical tests.
Leadership Roles at Bio-Techne
James Hippel - Executive Vice President & Chief Financial Officer
James Hippel, the Executive Vice President & Chief Financial Officer at Bio-Techne, oversees all financial planning, management, and reporting. Hippel directs Bio-Techne's financial strategy, ensuring fiscal responsibility and driving profitable growth in the life sciences sector. This executive leadership position involves managing investments, capital allocation, and financial risk to support the company's mission of providing innovative tools for research and diagnostics. By guiding financial operations, James Hippel ensures the resources are available to fuel scientific discovery and the development of critical diagnostic solutions. Hippel's financial acumen is instrumental in maintaining Bio-Techne's strong market position and enabling its continued expansion into new areas of biological research and clinical application.
William Geist - President, Protein Sciences Segment
William Geist, the President, Protein Sciences Segment at Bio-Techne, leads the strategic direction and operational execution for the company's protein sciences division. Geist drives innovation and growth within this segment, focusing on developing and delivering high-quality protein-based tools and reagents for scientific research. This leadership role involves overseeing product development, market strategy, and customer engagement to ensure Bio-Techne's offerings meet the evolving needs of researchers investigating biological processes. By championing advancements in protein science, William Geist directly contributes to accelerating discoveries in areas such as drug development and disease understanding. Geist's leadership ensures the Protein Sciences Segment remains a cornerstone of Bio-Techne's commitment to empowering scientific exploration.

Steve Crouse - President, Diagnostics & Spatial Biology Segment
Steve Crouse, the President, Diagnostics & Spatial Biology Segment at Bio-Techne, directs the strategic vision and operational performance of this key business unit. Crouse focuses on advancing Bio-Techne's capabilities in diagnostic solutions and spatial biology, enabling more precise disease detection and research. This executive role involves guiding the development of innovative technologies and products that support accurate clinical tests and deepen the understanding of biological systems at a cellular level. By leading the Diagnostics & Spatial Biology Segment, Steve Crouse ensures Bio-Techne provides critical tools that empower clinicians and researchers to make significant advancements. Crouse's leadership is essential for expanding the company's impact on patient care and scientific discovery.

Gary Latham - Chief Technology Officer
Gary Latham, the Chief Technology Officer at Bio-Techne, directs the company's technological vision and innovation strategy. Latham oversees the development and implementation of cutting-edge technologies that enhance Bio-Techne's product portfolio, supporting scientific investigations into biological processes and disease. This leadership role involves guiding research and development efforts to create advanced tools and bioactive reagents for the research and clinical diagnostic communities. By fostering a culture of technological excellence, Gary Latham ensures Bio-Techne remains at the forefront of life sciences innovation, directly contributing to advancements in drug discovery and the accuracy of clinical tests. The CTO's focus extends to exploring new technological frontiers that will shape the future of diagnostics and therapeutic development, ensuring the company's sustained competitive advantage in a rapidly evolving market.
Laurie Gilman - Vice President, Finance Operations & Chief of Staff
Laurie Gilman, the Vice President, Finance Operations & Chief of Staff at Bio-Techne, manages critical financial operations and provides strategic support to executive leadership. Gilman ensures the efficiency and integrity of financial processes, aligning operational execution with Bio-Techne's overarching business objectives. This dual role involves optimizing financial workflows and acting as a key liaison across departments, facilitating seamless communication and strategic alignment. By overseeing finance operations, Laurie Gilman contributes to the company's financial health and operational effectiveness, supporting the delivery of innovative tools for research and diagnostics. The Chief of Staff function further empowers Gilman to drive key initiatives and enhance executive decision-making, ensuring Bio-Techne's continued growth and impact in the life sciences sector.
Brenda Everson - Senior Vice President. Chief Human Resources Officer
Brenda Everson, the Senior Vice President. Chief Human Resources Officer at Bio-Techne, leads all human capital strategies and initiatives. Everson cultivates a robust organizational culture that supports Bio-Techne's mission of advancing life sciences research and diagnostics. This executive position involves developing and implementing comprehensive HR programs, including talent acquisition, employee development, and compensation strategies, all designed to attract and retain top talent. By focusing on human resources, Brenda Everson ensures the company possesses the skilled workforce necessary to drive innovation in biological processes and disease research. Everson's leadership is pivotal in fostering an environment where scientific discovery and the development of critical diagnostic tools can thrive, reinforcing Bio-Techne's position as a global leader.
Matthew Mehlbrech - Vice President, Information Technology & Chief Information Officer
Matthew Mehlbrech, the Vice President, Information Technology & Chief Information Officer at Bio-Techne, directs the company's IT infrastructure and digital strategy. Mehlbrech ensures robust and secure information systems that support Bio-Techne's global operations, from research and development to clinical diagnostics. This critical role involves overseeing the implementation of technology solutions that enhance operational efficiency and data integrity across the organization. By managing IT resources, Matthew Mehlbrech enables the seamless flow of information essential for scientific investigations and the development of innovative tools. The CIO's strategic vision is key to leveraging technology for competitive advantage, ensuring Bio-Techne can effectively deliver on its mission to advance life sciences and improve patient outcomes through accurate diagnostics.
Cheryl Bethune - Senior Vice President & Chief Human Resources Officer
Cheryl Bethune, the Senior Vice President & Chief Human Resources Officer at Bio-Techne, spearheads the company's human resources strategy and execution. Bethune focuses on building and nurturing a high-performing workforce that drives Bio-Techne's innovation in life sciences and diagnostics. This senior leadership role encompasses talent management, organizational development, and fostering a positive employee experience to support the company's ambitious goals. By championing HR best practices, Cheryl Bethune ensures Bio-Techne attracts, develops, and retains the specialized talent required for cutting-edge research and the creation of advanced bioactive reagents. Bethune's commitment to human capital is vital for sustaining the company's growth and its ability to deliver impactful solutions to the research and clinical communities.
Explore Leadership Teams in Business Services
For nearly four decades, FTI has proudly served the United States Department of Defense, Intelligence Community and the Federal Government with mission-tailored, technology-enabled solutions to help them make the best decisions possible for their missions.Headquartered in Dayton, Ohio, FTI has seven additional facilities with varying levels of clearance, along with a presence in 39 states and Puerto Rico.
Company Leadership JL
GM
CS
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic.
Company Leadership SY


DL
Brookings Institution operates as a nonprofit public policy research organization dedicated to generating actionable insights that address complex societal challenges. The organization conducts rigorous, in-depth research across multiple domains, translating academic inquiry into practical solutions for policymakers, business leaders, and civic stakeholders. Through its multidisciplinary approach, Brookings examines pressing issues spanning economics, governance, international affairs, and social policy, producing analysis that informs decision-making at local, national, and global scales. The institution's research methodology combines empirical investigation with expert analysis, drawing on scholars and practitioners who bring deep subject matter expertise to their work. Brookings produces comprehensive reports, policy briefs, and thought leadership that synthesize complex data into accessible recommendations. The organization's work spans both domestic policy challenges and international relations, reflecting the interconnected nature of modern governance and economic systems. Brookings maintains a commitment to nonpartisan analysis, striving to present evidence-based perspectives that transcend ideological boundaries. The institution engages with government officials, corporate executives, nonprofit leaders, and the broader public through publications, conferences, and direct consultation.
Company Leadership ES
ST
SS

Founded in 1952, The Research Foundation for Mental Hygiene is a nonprofit organization that works to assist and enhance research and training objectives within New York state departments, including the Office of Mental Health, Officer for People with Development Disabilities and the Office of Alcoholism and Substance Abuse Services. The nonprofit organization is headquartered in Orangeburg, New York.
Company Leadership AA
BS
PM
RP